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Abstract 
 
Microspheres are multiparticulate drug delivery systems which are prepared to obtain prolonged or controlled drug 
delivery to improve bioavailability, stability and to target the drug to specific site at a predetermined rate. They are 
made from polymeric waxy or other protective materials such as natural, semi synthetic and synthetic polymers. 
Microspheres are characteristically free flowing powders having particle size ranging from 1-1000 μm consisting of 
proteins or synthetic polymers. . The present review highlights various types of microspheres, different methods of 
preparation, its applications and also various parameters to evaluate their efficiency. Microspheres are various types 
like Bioadhesive microspheres, Magnetic microspheres, Floating microspheres, Radioactive microspheres, 
Polymeric microspheres, Biodegradable polymeric microspheres, Synthetic polymeric microspheres and are 
prepared by methods like Spray Drying, Solvent Evaporation, Single emulsion technique, Double emulsion 
technique, Phase separation coacervation technique, Spray drying and spray congealing, Solvent extraction. 
Microspheres have wide range of applications because of controlled and sustained release. This article also focuses 
on the various drugs that can be formulated into microspheres for controlled and sustained release.  
Keywords: Microspheres, controlled, polymer, multiparticulate. 
Introduction  
Microspheres are small spherical particles with 
diameters from 1 to 1000μm (or 50nm to 2mm) [1]. 
In some cases, microspheres are also known 
as microparticles. Microspheres can be produced 
from several natural and synthetic polymeric 
materials or even from inorganic materials For 
example, microspheres can be produced from 
commercially available polymers or ceramics. 
Depending on the method, solid or porous 
microspheres can be obtained for specific intended 
applications. 
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The variety of methods for the production of 
microspheres offers a myriad of opportunities to 
control the aspects of administration of the 
pharmaceutical compound. This focus facilitates the 
precise release of the desired amount of a component 
at the site of action and its reduction at non-target 
sites. Similarly, this factor guarantees the protection 
of the compounds before and after administration.  
Additionally, the vectorization of pharmaceutical 
compounds can be manipulated by coupling a 
recognition molecule to the microsphere. The 
exploitation of these changes in pharmacokinetic 
behavior can lead to an improved therapeutic effect. 
The aim of any pharmaceutical compound 
administration system is to provide a therapeutic 
amount of the compound at the correct site in the 
body to quickly achieve an effective concentration 
and then maintain it for a given time. A well-
designed modified release system for the compound 
can overcome some of the problems of conventional 
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therapy and improve the therapeutic efficiency, thus improving the patient’s quality of life. [2] 
 
 
Fig 1:Microspheres 
History and development 
The concept of drug delivery has been 
revolutionized. The strides have been made to lend 
the patient derive maximum benefits of drug. The 
drug should be delivered to specific target sites at a 
rate and concentration that permit optimum 
therapeutic efficacy while reducing side effects to 
minimum. Another aspect to be considered in drug 
delivery is patient compliance during drug therapy. 
[1] The concept of the advanced drug delivery system 
especially those offering a sustained and controlled 
action of drug to desired area of effect, attained great 
appeal for nearly half a century. However, actual 
practice of controlled release began with advent of 
timed release coating of the pills or solid drug 
particles in order to mask their unacceptable taste or 
make them more palatable. [1] Between 1940 and 
1960s, the concept of microencapsulation technology 
began as an alternative means of delivering drugs. In 
continued quest for more refined systems, in 1980s, 
polymer/membrane technology came to be known at 
forefront. Further, the process of targeting and site 
specific delivery with absolute accuracy can be 
achieved by attaching bioactive molecule to 
liposomes, bioerodible polymer, implants, 
monoclonal antibodies and various particulate 
carriers (e.g., nanoparticles and microspheres, etc). 
The microparticle delivery systems are considered 
and accepted as reliable means to deliver the drug to 
the target site with specificity. [1]A very good 
example of the development of one of the 
microspheres is microspheres intended for the 
Treatment of Vascular Complications of the Eye.The 
objective of this study was to design 1, 3, and 6 
month sustained-release poly lactide-co-glycolide 
(PLGA) microspheres of SAR 1118, a lymphocyte 
function-associated antigen-1 antagonist, using 
Design of Experiments. A full-factorial design was 
used to identify the polymers suitable for degradation 
in 1, 3, and 6 months and the Box-Behnken design 
was used to study the influence of the polymer type, 
polymer concentration, and drug to polymer ratio on 
drug loading, burst release, and particle size. From 
the full-factorial design, PLGA (50:50), PLGA 
(75:25), and PLGA (85:15) with an inherent viscosity 
of 0.3–0.5 dL/g were identified as polymers suitable 
for degradation in 1, 3, and 6 months, respectively. 
From the Box-Behnken design, the optimized 
polymer concentration (12% w/v) and drug to 
polymer ratio (0.15) were identified and used to 
prepare the SAR 1118-encapsulated microspheres 
with the above 3 polymers and evaluated for drug 
loading, burst release, and sustained drug release. 
The burst release in these 3 batches was less than 
20% and the drug loading ranged from 15%–18%. 
More than 90% of SAR 1118 release from PLGA 
(50:50), PLGA (75:25), and PLGA (85:15) 
microspheres occurred in 1, 3, and 6 months, 
respectively. Thus, the in vitro cumulative release 
data are remarkably close to the predicted values. The 
results demonstrated the potential of the Design of 
Experiments in designing theSAR 1118 microspheres 
with a high loading efficiency, low burst release, and 
sustained release for a desired duration. [3] 
Material Used 
A number of different substances both biodegradable 
as well as non-biodegradable have been investigated 
for the preparation of microspheres. These materials 
include the polymers of natural and synthetic origin 
and also modified natural substances.  
Classification of Polymers 
Synthetic Polymers 
Non biodegradable 
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 PMMA 
 Acrolein 
 Glycidyl methacrylate 
 Epoxy polymers 
 Lactides and glycolides and their 
copolymers 
 Polyalkylcyano acrylates 
 Polyanhydrides 
Natural Materials 
Proteins 
 Albumins 
 Gelatin  
 Collagen 
Carbohydrates  
 Starch 
 Agarose 
 Carrageenan 
 Chitosan 
Chemically modified carbohydrates 
 DEAE cellulose 
 Poly(acryl) dextran 
 Poly(acryl) starch 
 Targetability 
 Polyvalent [1] 
Types of microspheres[4] 
1. Bioadhesive microspheres  
2. Magnetic microspheres 
 3. Floating microspheres 
 4. Radioactive microspheres 
 5. Polymeric microspheres 
i. Biodegradable polymeric microspheres 
ii. Synthetic polymeric microspheres 
Bioadhesive microspheres  
The sticking of drug to membrane by using the 
sticking property can be defined Adhesion of 
water soluble polymers. This type of 
microsphere exhibits a prolonged residence 
time at the site of application.  E.g. adhesion of 
the drug delivery device to the mucosal 
membrane such as buccal, ocular, rectal, nasal 
etc. 
 
Fig 2: Bioadhesive microspheres 
Magnetic microspheres  
This type of delivery system is very much important 
for localizing the drug to the disease site in which 
larger amount of freely circulating drug can be 
replaced by small amount of magnetically targeted 
drug. Magnetic carriers receive magnetic responses to 
a magnetic field. 
 
Fig 3:Magnetic microspheres 
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Floating microspheres  
In floating microspheres the bulk density is less than 
the gastric fluid therefore it remains buoyant in 
stomach without affecting on gastric emptying rate. 
Drug is released slowly at the desired rate of the site. 
it also reduces chances of striking and dose dumping 
Produces. 
 
Fig 4: Floating microspheres 
 Radioactive microspheres  
Radio imobilisation therapy microspheres having 
sized 10- 30 nm are of larger than capillaries. They 
are injected to arteries which lead to tumor of 
interest. These radioactive microspheres deliver high 
radiation dose to targeted areas without damaging the 
normal tissues. Different types of radioactive 
microspheres are α emitters, β emitters, γ emitters. 
 
Fig 5: Radioactive microspheres 
 Polymeric microspheres The different types of 
polymeric microspheres classified as 
i. Biodegradable polymeric microspheres 
Natural polymers such as starch are used as 
concept that they are biodegradable, 
biocompatible, and also Bioadhesive in 
nature. These polymers prolongs the 
residence time when contact with mucous 
membrane due to its high degree of swelling 
property with aqueous medium, results get 
gel formation. 
ii. Synthetic polymeric microspheres 
Synthetic polymeric microspheres are 
widely used in clinical application, that are 
also used as bulking agent, fillers, embolic 
particles and drug delivery vehicles etc. and 
proved to be safe and biocompatible but the 
disadvantage of these kind of microspheres, 
are tend to migrate away from injection site 
and lead to potential risk, embolism ,further 
organ damage. 
General methods of Preparation[1] 
The microspheres can be prepared by using any of 
the several techniques discussed in the following 
sections, but the choice of technique mainly depends 
on the nature of polymer used, the drug, the intended 
use and the duration of therapy. Moreover, the 
method of preparation and its choice are equivocally 
determined by some formulation and technology 
related factors as mentioned below: 
1. The particle size requirement 
2. The drug or the protein should not be adversely 
affected by the process 
3. Reproducibility of the release profile and the 
method 
4. No stability problem 
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5. There should be no toxic product(s) associated 
with the final product. 
 
Simple Emulsion Technique 
The microparticulate carriers of natural polymers, i.e. 
those of proteins and carbohydrates are prepared by 
single emulsion technique. The natural polymers are 
dissolved or dispersed in aqueous medium followed 
by dispersion in the non-aqueous medium e.g., oil. In 
the second step of preparation, cross-linking can be 
achieved either by means of heat or by using the 
chemical cross linkers. The chemical cross-linking 
agents used include glutaraldehyde, formaldehyde, 
terephthaloyl chloride, diacid chloride, etc. Cross-
linking by heat is affected by adding the dispersion to 
previously heated oil. Heat denaturation is however, 
not suitable for the thermolabile drugs while the 
chemical cross-linking suffers disadvantage of 
excessive exposure of active ingredient to chemicals 
if added at the time of preparation. 
Fig 6: Schematic representation of simple emulsion based method of Microspheres preparation 
 
Double emulsion technique 
Briefly, double emulsion method of microspheres 
preparation involves the formation of multiple 
emulsions or double emulsion of type w/o/w and is 
best suited to the water- soluble drugs, peptides, 
proteins and the vaccines. This method can be used 
with both the natural as well as synthetic polymers. 
The aqueous solution is dispersed in a lipophilic 
organic continuous phase. This protein solution may 
contain the active constituents. The continuous phase 
is generally consisted of the polymer solution that 
eventually encapsulates of the protein contained in 
dispersed aqueous phase. The primary emulsion is 
then subjected to the homogenization or the 
sonication before addition to the aqueous solution of 
the poly vinyl alcohol (PVA). This results in the 
formation of a double emulsion. The emulsion is then 
subjected to solvent removal either by solvent 
evaporation or by solvent extraction process. 
 
Fig 7: Schematic representation of double Emulsion Method of Microspheres Preparation  
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The solvent evaporation is carried out by maintaining 
emulsion at reduced pressure or by stirring the 
emulsion so that the organic phase evaporates out. In 
the later case, the emulsion is added to the large 
quantity of water (with or without surfactant) into 
which organic phase diffuses out. The solid 
microspheres are subsequently obtained by filtration 
and washing. A number of hydrophilic drugs like 
leutinizing hormone releasing hormone (LH-RH) 
agonists, vaccines, protein/ peptides and conventional 
molecules are successfully incorporated in to the 
microspheres using the method of double emulsion 
solvent evaporation/extraction. 
 
Polymerization Techniques 
 
The polymerization techniques conventionally used 
for the preparation of the microspheres are normally 
classified as: 
1. Normal polymerization 
2. Interfacial polymerization 
Normal polymerization 
The two processes are carried out in a liquid phase. 
Normal polymerization proceeds and carried out 
using different techniques as bulk, suspension, 
precipitation, emulsion and miceller polymerization 
process. The bulk polymerization, a monomer or a 
mixture of monomer along with the initiator is 
usually heated to initiate the polymerization and carry 
out the process. The catalyst or the initiator is added 
to the reaction mixture to facilitate or accelerate the 
rate of the reaction. The polymer so obtained may be 
moulded or fragmented as microspheres. For loading 
of drug, absorptive drug loading or adding drug 
during the process of polymerization may be opted. 
 
Fig 8:Bulk polymerization Fig 9:Suspension polymerization 
 
The suspension polymerization which is also referred 
as the bead or pearl polymerization is carried out by 
heating the monomer or mixture of monomer with 
active principle as droplets dispersion in a continuous 
aqueous phase. The droplets may also contain an 
initiator and other additives.The emulsion 
polymerization however differs from the suspension 
polymerization as due to presence of initiator in the 
aqueous phase, which later on diffuses to the surface 
of the micelles or the emulsion globules. The bulk 
polymerization has an advantage of formation of the 
pure polymer, but it also suffers a disadvantage, as it 
is very difficult to dissipate the heat of reaction, 
which can adversely affect the thermolabile active 
ingredients. On the other hand suspension and 
emulsion polymerization can be carried out at lower 
temperature, since continuous external phase is 
normally water through which heat can easily 
dissipate. The two processes also lead to the 
formation of the higher molecular weight polymer at 
relatively faster rate. The major disadvantage of 
suspension and emulsion polymerization is, 
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association of polymer with the unreacted monomer and other additives. 
 
 
Fig 10: Schematic Representation of Emulsion Polymerization 
 
Fig 11: Polymerization in micelles having monomer globules  
 
 
Interfacial polymerization 
Interfacial polymerization essentially proceeds, 
involving reaction of various monomers at the 
interface between the two immiscible liquid phases to 
form a film of polymer that essentially envelops the 
dispersed phase. In this technique two reacting 
monomers are employed; one of which is dissolved 
in the continuous phase while the other being 
dispersed in continuous phase. The monomers 
present in either phases diffuse rapidly and 
polymerize rapidly at interface. Two conditions arise 
depending upon the solubility of formed polymer in 
the emulsion droplet. If the polymer is soluble in 
droplet it will lead to the formation of the monolithic 
type of carrier on the other hand if the polymer is 
insoluble in the monomer droplet, the formed carrier 
is of capsular (reservoir) type. The interfacial 
polymerization is not widely used in the preparation 
of the microparticles because of certain drawbacks, 
which are associated with the process such as: 
 Toxicity associated with the unreacted monomer 
 High permeability of the film 
 High degradation of the drug during 
polymerization 
 Fragility of microcapsules 
 Non-biodegradability of the microparticles 
 
Phase Separation Coacervation Technique 
Phase separation method is specially designed for 
preparing the reservoir type of the system, i.e. to 
encapsulate water soluble drugs e.g. peptides, 
proteins, however, some of the preparations are of 
matrix type particularly, when the drug is 
hydrophobic in nature e.g. steroids.  
  
 
International Journal of Health and Clinical Research, 2020;3(1):11-24                    e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
____________________________________________________________________________________________________________________________________________
Gurung and Kakar         International Journal of Health and Clinical Research, 2020; 3(1):11-24 
www.ijhcr.com                              
        18 
 
 
Fig 12: Schematic representation of Microspheres Formulation by Phase Separation Method 
The process is based on the principle of decreasing 
the solubility of the polymer in the organic phase to 
affect the formation of  polymer rich phase called the 
coacervates. In this technique, the polymer is first 
dissolved in a suitable solvent and then drug is 
dispersed by making its aqueous solution, if 
hydrophilic or dissolved in polymer solution itself, if 
hydrophobic. Phase separation is then accomplished 
by changing the solution conditions by using methods 
such as salt addition, non solvent addition, addition 
of the incompatible polymer or change in pH. The 
process is carried out under continuous stirring to 
control the size of the microparticles.  
 
 
 
Spray drying and spray congealing 
Spray drying and spray congealing methods are based 
on drying of the mist of the polymer and drug in the 
air. Depending upon the removal of the solvent or the 
cooling of the solution, the two processes are named 
the spray drying spray congealing respectively. The 
polymer is first dissolved in the suitable volatile 
organic solvent such as dichloromethane, acetone, 
etc. the drug in the solid form is then dispersed in the 
polymer solution under high speed homogenization. 
This dispersion is then atomized in a stream of hot 
air. The atomization leads to the formation of small 
droplets or the fine mist from which the solvent 
evaporates instantaneously leading to the formation 
of microspheres in a size range 1-100µm. 
microparticles are separated from the hot air by 
means of the cyclone separator while the traces of 
solvent are removed by vacuum drying.  
 
 
 
Fig 13:Solvent extraction 
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Solvent extraction method used for preparation of 
microparticles, involves removal of organic phase by 
extraction of organic solvent. The method involves 
water miscible organic solvents such as isopropanol. 
Organic phase is removed by extraction of water. 
This process decreases the hardening time for the 
microspheres. One variation of the process involves 
direct addition of the drug or protein to polymer 
organic solution. The rate of solvent removal by 
extraction method depends on the temperature of 
water, ratio of emulsion volume to the water and the 
solubility profile of the polymer.    
Advantages and disadvantages of microspheres 
Advantages of Microspheres: [12] 
• Size reduction leads to increase in surface area 
which can enhance solubility of the poorly soluble 
drug. 
• Provide constant drug concentration in blood which 
can increase patent compliance, 
• Decrease dose and toxicity.  
• Coating of drug with polymers helps the drug from 
enzymatic cleavage hence found to be best for drug 
delivery.  
• Less dosing frequency leads to better patient 
compliance.  
• Better drug utilization will improve the 
bioavailability and reduce the incidence or intensity 
of adverse effects. 
• Protects the GIT from irritant effects of the drug.  
• Convert liquid to solid form and to mask the bitter 
taste. 
• Reliable means to deliver the drug to the target site 
with specificity, if modified, and to maintain the 
desired concentration at the site of interest without 
untoward effects. 
• Reduce the reactivity of the core in relation to the 
outside environment. 
• Biodegradable microspheres have the advantage 
over large polymer implants in that they do not 
require surgical procedures for implantation and 
removal.  
• Controlled release delivery biodegradable 
microspheres are used to control drug release rates 
thereby decreasing toxic side effects, and eliminating 
the inconvenience of repeated injections[10] 
 Limitation: [12] 
 Some of the disadvantages were found to be as 
follows [5] 
 1. The costs of the materials and processing of the 
controlled release preparation are substantially higher 
than those of standard formulations. 
 2. The fate of polymer matrix and its effect on the 
environment. 
 3. The fate of polymer additives such as plasticizers, 
stabilizers, antioxidants and fillers. 
 4. Reproducibility is less. 
 5. Process conditions like change in temperature, pH, 
solvent addition, and evaporation /agitation may 
influence the stability of core particles to be 
encapsulated. 
  
Application of Microspheres in Pharmaceutical 
Industry: [5] 
Microspheres developed using polymer exhibits 
favourable biological behaviour such as bioadhesion, 
permeability-enhancing properties, and interesting 
physicochemical characteristics, which make it a 
unique material for the design of ocular drug delivery 
vehicles. e.g. Chitosan, Alginate, Gelatin  
1. Oral Drug Delivery: The ability of microspheres 
containing polymer to form films permit its use in the 
formulation of film dosage forms, as an alternative to 
pharmaceutical tablets. The pH sensitivity, coupled 
with the reactivity of the primary amine groups, make 
microspheres more suitable for oral drug delivery 
applications. e.g. Chitosan, Gelatin. 
2. Gene Delivery: Microspheres could be a useful 
oral gene carrier be-cause of its adhesive and 
transport properties in the GI tract. e.g. Chitosan, 
Gelatin, viral vectors, cationic liposome, polycation 
complexes and Gene therapy with DNA plasmids and 
also delivery of insulin. It is also beneficial in 
vaccine delivery also as the prerequisite of a vaccine 
is protection against the microorganism or its toxic 
product. Biodegradable delivery system for vaccines 
that are given by Parenteral route may overcome the 
shortcoming of conventional vaccines. Several 
parenteral vaccines have been encapsulated in 
biodegradable polymeric microspheres, including the 
tetanus and diphtheria vaccine. 
3. Nasal Drug Delivery: Polymer based drug delivery 
systems, such as micro-spheres, liposomes and gels 
have been demonstrated to have good bioadhesive 
characteristics and swell easily when in contact with 
the nasal mucosa increasing the bioavailability and 
residence time of the drugs to the nasal route. e.g. 
Starch, Dextran, Albumin, Chitosan + Gelatin  
4. Intratumoral and Local Drug Delivery: In order to 
deliver paclitaxel at the tumor site in therapeutically 
relevant concentration, polymer films are fabricated. 
Mixture of drug has promising potential for use in 
controlled delivery in the oral cavity e.g. Gelatin, 
PLGA, Chitosan. 
5. Buccal Drug Delivery: Polymer is an excellent 
polymer to be used for buccal delivery because it has 
muco / bioadhesive properties and can act as an 
absorption enhancer. Chitosan, Sodium alginate. 
6. Gastrointestinal Drug Delivery: Polymer granules 
having internal cavities prepared by de acidification 
when added to acidic and neutral media are found 
buoyant and provided a controlled release of the drug 
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e.g. Eudragit, Ethyl cellulose + Carbopol BSA, 
Gelatin. 
7. Transdermal Drug Delivery: Polymer has good 
film-forming properties. The drug release from the 
devices is affected by the membrane thickness and 
cross-linking of the film. e.g. Chitosan, Alginate, 
PLGA.  
9. Imaging: Diameter of microspheres plays an 
important role in determining the imaging of targeted 
sites using already labelled microspheres having 
radio activity. The microspheres injected via IV route 
apart from the portal vein will usually become 
entrapped in the area of lungs. This phenomenon is 
specifically used for scintigraphic imaging of tumour 
masses in lungs using human serum albumin 
microspheres.  
10. Topical Porous Microspheres: Microsponges are 
porous microspheres having myriad of interconnected 
voids of size range 5 to 300µm. these sponges having 
capacity to engulf the various active ingredients such 
as emollients, fragrances, essential oils which is used 
for the topical application 40 .  
11. Medical Application: • Release of proteins, 
peptides and hormones over the extended period of 
time. • Passive targeting of leaky tumor vessels, 
active targeting of tumor cells, antigens, by parenteral 
route. • Magnetic Microspheres can be used for used 
for stem cell extraction and bone marrow purging. • 
Used for Various diagnostic test for infectious 
disease like bacterial, viral and fungal.  
12. Radioactive Application: It can be beneficial for 
the embolisation of various liver and spleen tumors 
which is used for radio synvectomy of local 
radiotherapy, arthritis, imaging of liver, bone 
marrow, local radiotherapy and even imaging of 
thrombus in deep vein thrombosis can be done.  
13. Other Applications: Fluorescent microspheres can 
be used for membrane based technology flow 
cytometry, cell biology, fluorescent linked 
immunosorbent assay. Yttrium 90 can be used for 
primary treatment of carcinoma and also used for pre 
transplant management of HCC with promising 
results.  
14. Colonic Drug Delivery: Polymer has been used 
for the specific delivery of insulin to the colon e.g. 
Chitosan. 
 15. Vaginal Drug Delivery: Polymer, modified by 
the introduction of thioglycolic acid to the primary 
amino groups of the polymer is widely used for the 
treatment of mycotic infections of the genitourinary 
tract e.g. Chitosan, Gelatin, PLGA. 
16. Targeting by Using Micro Particulate Carriers: 
The concept of targeting is a well established dogma, 
which is gaining full attention now a days. The 
response produced by the drug depends on its access 
and interaction with receptor usually pellets method 
is reported which can be prepared by using extrusion 
/ Spheronization technology e.g. microcrystalline 
cellulose (MCC) and chitosan. 
Evaluation 
Physiochemical Evaluation 
Characterization Particle size and shape 
Light microscopy (LM) provides a control over 
coating parameters in case of doublewalled 
microspheres. The microspheres structures can be 
visualized before and after coating and the change 
can be measured microscopically[27].Scanning 
electron microscopy (SEM) allows investigations of 
the microspheres surfaces and after particles are 
cross-sectioned, it can also be used for the 
investigation of double walled systems.  
1.Attenuated total reflectance FT-IR Spectroscopy: 
FT-IR is used to determine the degradation of the 
polymeric matrix of the carrier system. The surface 
of the microspheres is investigated measuring 
alternated total reflectance (ATR). The ATRFT-IR 
provides information about the surface composition 
of the microspheres depending upon manufacturing 
procedures and conditions.[28 ] 
2.Density determination: The density of the 
microspheres can be measured by using a multi 
volume pycnometer. Accurately weighed sample in a 
cup is placed into the multi volume pycnometer. 
Helium is introduced at a constant pressure in the 
chamber and allowed to expand. This expansion 
results in a decrease in pressure within the chamber. 
Two consecutive readings of reduction in pressure at 
different initial pressure are noted. From two pressure 
readings the density of the microsphere carrier is 
determined. 
 3.Isoelectric point: The micro electrophoresis is an 
apparatus used to measure the electrophoretic 
mobility of microspheres from which the isoelectric 
point can be determined. The mean velocity at 
different PH values ranging from 3-10 is calculated 
by measuring the time of particle movement over a 
distance of 1 mm. By using this data the electrical 
mobility of the particle can be determined.  
4.Entrapment efficiency: Microspheres containing of 
drug (5mg) were crushed and then dissolved in 
distilled water with the help of ultrasonic stirrer for 3 
hr., and was filtered then assayed by uv-vis 
spectroscopy. Entrapment efficiency is equal to ratio 
of actual drug content to theoretical drug content[5] 
 % Entrapment = Actual content/Theoretical content 
x 100 
5.Swelling index: This technique was used for 
Characterization of microspheres were performed 
with swelling index technique Different solution 
(100mL) were taken such as (distilled water, buffer 
solution of pH(1.2, 4.5, 7.4) were taken and 
microspheres (100mg) were placed in a wire basket 
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and kept on the above solution and swelling was 
allowed at 37oC and changes in weight variation 
between initial weight of microspheres and weight 
due to swelling was measured by taking weight 
periodically and soaking with filter paper 
 6.Angle of contact: The angle of contact is measured 
to determine thewetting property of a micro 
particulate carrier. It determines the nature of 
microspheres in terms of hydrophilicity or 
hydrophobicity. The angle of contact is measured at 
the solid/air/water interface. The angle of contact is 
measured by placing a droplet in a circular cell 
mounted above objective of inverted microscope. 
Contact angle is measured at 200C within a minute of 
deposition of microspheres. 
In Vitro Methods  
 
Beaker method 
 
The dosage form in this method is made to adhere at 
the bottom of the beaker containing the medium and 
stirred uniformly using over head stirrer. Volume of 
the medium used in the literature for the studies 
varies from 50-500 ml and the stirrer speed form 60-
300 rpm. 
 
Interface diffusion system  
 
This method is developed by Dearden& Tomlinson. 
It consists of four compartments. The compartment A 
represents the oral cavity, and initially contained an 
appropriate concentration of drug in abuffer. The 
compartment B representing the buccal membrane, 
contained 1-octanol, and compartment C representing 
body fluids, contained 0.2 M HCl. The compartment 
D representing protein binding also contained 1-
octanol. Before use, the aqueous phase and 1-octanol 
were saturated with each other. Samples were with 
drawn and returned to compartment A with a syringe. 
 
Modified Keshary Chien Cell 
 
 A specialized apparatus was designed in the 
laboratory. It comprised of a KesharyChien cell 
containing distilled water (50ml) at 370 C as 
dissolution medium. TMDDS (Trans Membrane 
Drug Delivery System) was placed in a glass tube 
fitted with a 10# sieve at the bottom which 
reciprocated in the medium at 30 strokes per min. 
 
Dissolution apparatus 
 
 Standard USP or BP dissolution apparatus have been 
used to study in vitro release profiles using rotating 
elements, paddle 26 and basket 27 Dissolution 
medium used for the study varied from 100-500 ml 
and speed of rotation from 50-100 rpm. 
 
Stability studies 
 
 By placing the microspheres in screw capped glass 
container and stored them at following conditions: ™ 
Ambient humid condition ™ 
 Room temperature (27+/-2 0C) ™ 
 Oven temperature (40+/-2 0C) ™ 
Refrigerator (5 0C -80C).   
It was carried out of a 60 days and the drug content 
of the microsphere was analysed. 
 
In Vivo Methods 
 
Animal models 
 
 Animal models are used mainly for the screening of 
the series of compounds, investigating the 
mechanisms and usefulness of permeation enhancers 
or evaluating a set of formulations In general, the 
procedure involves anesthetizing the animal followed 
by administration of the dosage form. In case of rats, 
the esophagus is ligated to prevent absorption 
pathways other than oral mucosa. At different time 
intervals, the blood is withdrawn and analyzed 
 
Buccal absorption test 
 
The buccal absorption test was developed by Beckett 
&Triggs in 1967. It is a simple and reliable method 
for measuring the extent of drug loss of the human 
oral cavity for single and multi component mixtures 
of drugs. The test has been successfully used to 
investigate the relative importance of drug structure, 
contact time, initial drug concentration and Ph of the 
solution while the drug is held in the oral cavity[16-
18] 
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Table 1:Various drugs for microspheres and their applications 
 
 
 
Drugs Method of preparation Application References 
Risperidone Double emulsion (o/w) Antipsychotic 
Treatment of bipolar disorder and Schizophrenia  
[10,11] 
Naltrexone  Double emulsion (o/w) Treatment of alcohol and opoid abuse  [10,11] 
Leuprolide  Double emulsion (o/w/o) Treatment of prostate cancer   [11] 
Somatropin Phase separation technique  
(cryogenic spray drying) 
Treatment of growth hormone deficiency  [10,11] 
Octreotide Phase separation technique  
(cryogenic spray drying) 
Treatment of severe watery diarrhea and Acromegaly [10,11] 
Triptorelin Phase separation  Stimulates Gonadotrophin Releasing hormone(GnRH) i.e. 
LHRH  
 [11] 
Buserelin NA  Treatment of endometriosis   [11] 
Lanreotide Spray drying  Parkinsonism treatment   [11] 
Minocycline  NA Treatment of Gastroenteropancreatic neuroendocrine 
tumors (GEPNET) 
[10,11] 
Bromocriptine Spray drying  Parkinsonism treatment [10,11] 
Goserelin 
acetate  
NA Treatment of prostate cancer   [11] 
Recombinant 
bovine 
somatropin 
NA To increase milk product in cattle   [11] 
Fluorouracil Dry-in-oil For targeted delivery to treat cerebral tumors Antitumor 
activity 
[13] 
Cisplatin w/o emulsion system Antitumor activity [13] 
Mitoxantrone crosslinking technique Antitumor [13] 
Oxantrazo combined emulsion Anticancer [13] 
Aceclofenac  By dissolving drug in polymer  Anti-inflammatory drug [13] 
Amoxicillin Crosslinking for helicobacter pylori infection eliminating infection [13] 
Indomethacin Co-matrix method Antiinflammatory [13] 
Nifedipine Encapsulation Calcium channel blockers [13] 
Propranolol emulsification coacervation technique Calcium channel blockers [13] 
Progesterone Crosslinking Steroid [13] 
Insulin __ Antihyperglycemic effect [13] 
Furosemide Crosslinking Diuretics [13] 
Rifampicin Double emulsion Solvent Evaporation Treatment of Tuberculosis  [19] 
Moxifloxacin Spray Drying Respiratory infection [19] 
Beclomethasone
dipropionate 
Spray Drying Treatment of Asthma, COPD [19] 
Prostaglandin EI  W/O/W double emulsion solvent 
evaporation  
Treatment of Pulmonary Arterial Hypertension  [19] 
Ofloxacin W/O emulsion solvent evaporation  Treatment  of Pneumonia  [19] 
Lysozyme  W/O/W double emulsion solvent 
evaporation  
Treatment  of pulmonary disorder  [19] 
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Table 2: Types of Microspheres 
 
Types of 
Microsphere 
Method of 
preparation 
Application References  Types of 
Microsphere 
Therapeutic 
magnetic 
microspheres 
 
 
Multiple emulsion 
method  
Anticancer agent, Used in 
DNA analysis, cell 
isolation 
[5], [8][20] Therapeutic 
magnetic 
microspheres 
 
Diagnostic 
microspheres  
 
Emulsion solvent 
extraction method  
Magnetic resonance 
imaging contrast 
enhancement, 
detoxification of biological 
fluids, immunoassay, liver 
metastases. 
[5], [8] Diagnostic 
microspheres  
 
Bioadhesive 
microsphere  
 
_ 
Buccal, oral, ocular, nasal, 
colonic drug delivery. 
[5], [8] Bioadhesive 
microsphere  
Floating 
microspheres  
 
_ 
Increases the gastric 
resistance time,  
Carriers for drugs like 
antiviral, antifungal and 
antibiotic agents 
[5], [8] Floating 
microspheres  
Radioactive 
microspheres  
 
_ 
Radioimmobilization of 
liver and spleen cancer  
Local radiotherapy, 
radiosynvectomy of 
arthritis joint  
[5], [8] Radioactive 
microspheres  
Porous microsphere Seed swelling 
method 
Tissue regeneration 
scaffolds  
High speed protein 
chromatography  
Pulmonary drug delivery 
[9] Porous microsphere 
Therapeutic 
magnetic 
microspheres 
 
 
Multiple emulsion 
method  
Anticancer agent, Used in 
DNA analysis, cell 
isolation 
[5], [8] Therapeutic 
magnetic 
microspheres 
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